PANADE is a high-throughput screening platform that encapsulates protoplasts or algae in semi-permeable nanoliter compartments, enabling hundreds to thousands of conditions to be tested in parallel with minimal sample and reagent use. Automated high-content imaging and machine learning quantify phenotypes and rank promising conditions for accelerated biological discovery.
PANADE (Protoplast & Algae NAnoculture Discovery Engine) is an automated platform for high-throughput, plant-relevant biological screening. The technology addresses the limitations of conventional protoplast and algae screening, which relies on multiwell plates, repeated pipetting, and relatively large sample and reagent volumes. By miniaturizing and automating the workflow, PANADE reduces manipulation of fragile protoplasts and enables far more conditions to be tested per experiment, accelerating discovery while reducing hands-on time.
PANADE uses microfluidics to encapsulate protoplasts or algae within semi-permeable nanoliter compartments that retain cells while allowing controlled exchange of nutrients, signaling molecules, and screening compounds. Key features include:
The platform is designed for longitudinal monitoring of algae growth, fluorescence, and responses to chemical or environmental perturbations, as well as for screening applications involving fragile protoplasts.
PANADE is currently at an early development stage. A three-phase validation plan is proposed: first, optimizing the existing microfluidic encapsulation workflow for representative algae and protoplasts by tuning nanoculture size, cell loading, shell permeability, media composition, and osmotic conditions to maximize viability and stability. Second, establishing parallel screening workflows using nutrients, environmental stressors, and selected compounds across concentration gradients, with automated high-content imaging quantifying viability, growth, morphology, chlorophyll fluorescence, reporter expression, and treatment responses. Third, integrating machine-learning analysis to automatically identify nanocultures, quantify phenotypes, and rank conditions, followed by benchmarking against conventional multiwell assays for throughput, reproducibility, reagent consumption, hands-on time, and biological response. Successful completion will deliver a validated and scalable prototype.
Carnegie Mellon University is a private, global research university in Pittsburgh with a strong applied-research culture and an emphasis on translational impact. Industry collaborates through co-located labs, specialized testbeds, and a federally funded software engineering center that de-risks complex systems. Proximity to a regional robotics and advanced manufacturing cluster enables rapid prototyping, field trials, and access to a skilled talent pipeline, with flexible sponsored-research and affiliate models. Research is supported by competitive federal funding from agencies such as NSF, DoD, DOE, NIH, and NASA. A dedicated tech transfer office and entrepreneurship programs provide IP strategy, licensing, and startup acceleration.